Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study
International Journal of Clinical Practice,  Clinical Article

Mattarozzi K et al. – This first prospective study provides objective data showing that early disclosure of multiple sclerosis diagnosis improves both the patient's quality of life and psychological well–being. In addition, the results seem to suggest that clinically isolated syndrome disclosure does not lead to the same favourable effects.

Methods
  • Eligible participants were all patients referred for the first time to the Neurological Unit who had manifested symptoms suggestive of MS for no more than 6 months.
  • All patients were evaluated for
    • QoL (SEIQoL and MS-QoL54).
    • Anxiety (STAI) and Depression (CMDI) on study inclusion (T0), 30 days after diagnosis disclosure (T30), and after 1 (T1y) and 2 (T2y) years' follow-up.

Results
  • Two hundred and twenty-nine patients were enrolled; 93 of these were unaware of their diagnosis.
  • Patients who already knew their diagnosis (100 with CIS and 22 with MS) were excluded from the main analyses and used to perform control analyses.
  • At the end of the screening, an MS diagnosis was disclosed to 18 of the 93 patients, whereas a CIS diagnosis was disclosed to 62 patients (12 patients received a diagnosis other than MS or CIS).
  • Thirty days after diagnosis disclosure, irrespective of the diagnosis disclosed, both QoL and Anxiety and Depression were significantly rated as better compared to the start of screening, (ps < 0.03), and this improvement remained stable over the two annual follow-ups.
  • However, as suggested by a significant `Time' × `Diagnosis' interaction with regard to both QoL and Anxiety and Depression (ps < 0.02), the effect of the disclosure in the short term differed depending on CIS or MS diagnosis.
  • Specifically, on MSQoL, which is a health-related QoL scale, the authors found a statically significant improvement, immediately after the diagnosis disclosure, in both the MS and CIS groups (ps < 0.01).
  • Differently, on SEIQoL, which is a non health-related QoL measure, and on the anxiety scale, the authors observed a statistically significant improvement only in the group which received a MS diagnosis (ps < 0.03).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 Antidepressants and the risk of hyponatraemia: A class-by-class review of the literature Psychosomatics, September 15, 2014    Review Article

3 Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis Schizophrenia Research, September 24, 2014    Clinical Article

4 Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis European Neuropsychopharmacology, September 2, 2014    Evidence Based Medicine    Review Article

5 Prazosin in the treatment of PTSD Journal of Psychiatric Practice, July 25, 2014    Review Article

6 Association between early temperament and depression at 18 years Depression and Anxiety, August 18, 2014    Clinical Article

7 The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial Psychiatry Research, August 5, 2014    Clinical Article

8 Adipokines as emerging depression biomarkers: A systematic review and meta-analysis Journal of Psychiatric Research, September 18, 2014    Evidence Based Medicine    Clinical Article

9 Latent inhibition in ADHD adults on and off medication: A preliminary study Journal of Attention Disorders, September 10, 2014    Clinical Article

10 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 17, 2014    Clinical Article

11 Adipokines as emerging depression biomarkers: A systematic review and meta-analysis Journal of Psychiatric Research, September 3, 2014    Evidence Based Medicine    Clinical Article

12 Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial BMJ Open, September 9, 2014    Clinical Article

13 The importance of cytokines and autoantibodies in depression Autoimmunity Reviews, September 25, 2014    Review Article

14 Risk of diabetes in children and adolescents exposed to antipsychotics: A nationwide 12-year case-control study Journal of the American Academy of Child & Adolescent Psychiatry, September 4, 2014    Clinical Article

15 Increased cortisol awakening response was associated with time to recurrence of major depressive disorder Psychoneuroendocrinology, August 22, 2014    Clinical Article

16 Association between autoimmune thyroiditis and depressive disorder in psychiatric outpatients European Archives of Psychiatry and Clinical Neuroscience, September 17, 2014    Clinical Article

17 Oral contraceptive use and psychiatric disorders in a nationally representative sample of women Archives of Women's Mental Health, August 29, 2014    Clinical Article

18 Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression Journal of Psychiatric Research, September 19, 2014    Clinical Article

19 Efficacy of acupuncture in reducing preoperative anxiety: a meta-analysis Full Text Evidence-based Complementary and Alternative Medicine , September 5, 2014    Free full text    Evidence Based Medicine    Review Article

20 Metacognitions and thought control strategies in unipolar major depression: A comparison of currently depressed, previously depressed, and never-depressed individuals Cognitive Therapy and Research, September 5, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close